세계의 계산 생물학 시장 : 규모, 점유율, 성장 분석, 용도별, 최종 용도별, 서비스별, 지역별 산업 예측(2024-2031년)

Global Computational Biology Market size was valued at USD 5.7 billion in 2022 and is poised to grow from USD 6.75 billion in 2023 to USD 26.26 billion by 2031, growing at a CAGR of 18.5% during the forecast period (2024-2031).

The computational biology market is experiencing rapid growth, driven by increasing drug discovery R&D, a surge in demand for predictive models, and government funding initiatives. Leveraging theoretical concepts and computer simulations, this multidisciplinary field enables detailed exploration of biological systems, including genomics and pharmacology. Notable advancements include the Human Genome Project, which showcased the power of computing in genetic mapping. Collaborations, such as that between BeiGene and Ambrx, are enhancing drug development by integrating innovative platforms like the Expanded Genetic Code. With pharmaceutical companies shifting towards predictive modeling in response to rising costs and failure rates in clinical trials, the market is poised for significant expansion. Increased investment from both public and private sectors continues to bolster this dynamic sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Computational Biology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Computational Biology Market Segmental Analysis

Global Computational Biology Market is segmented by service, application, end-use and region. Based on service, the market is segmented into databases, infrastructure & hardware and software platform. Based on application, the market is segmented into drug discovery & disease modelling, preclinical drug development, clinical trial, computational genomics, computational proteomics and others. Based on end-use, the market is segmented into academic & research, pharmaceutical industry and industrial. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Computational Biology Market

The global Computational Biology market is projected to witness significant growth driven by the increasing demand for advanced computational tools for genome sequencing. As more sophisticated software becomes accessible, scientists can efficiently conduct tasks such as creating PCR primers, identifying restriction enzyme cut sites, and converting DNA sequences into amino acids. The expanding databases and sequence analysis tools empower researchers to extract valuable insights regarding gene structures and functions, thereby enhancing the drug development process. By pinpointing functionally relevant protein sequences from extensive datasets, these computational approaches facilitate the discovery of new therapeutic targets and enable the engineering of synthetic DNA sequences, which further promotes innovation and commercialization in biotechnology. This rapid advancement in sequencing technology and analytical tools is expected to substantially boost market revenue in the coming years.

Restraints in the Global Computational Biology Market

The global computational biology market faces significant constraints primarily due to a scarcity of skilled professionals and a lack of standardized practices. Expertise in this field requires a strong foundation in programming, mathematics, and statistics, along with a comprehensive understanding of cloud computing and biological sciences. The interdisciplinary nature of computational biology often results in an absence of a cohesive curriculum, which may impede the ability of recent graduates to enhance their skill sets effectively. Furthermore, the field currently lacks established methods for addressing issues such as allergic reactions and post-surgical complications, potentially hindering market revenue growth in the future.

Market Trends of the Global Computational Biology Market

The global computational biology market is experiencing a robust upward trend, primarily fueled by the surge in clinical studies focused on pharmacogenomics, which enhances understanding of diverse patient populations' biological frameworks. This growing emphasis on personalized medicine, along with the need for rapid drug discovery and streamlined scientific research processes, is driving demand for computational biology solutions. Moreover, the increasing integration of computational tools across epigenomics, proteomics, and metagenomics sectors is pivotal in elucidating protein structures and interactions. Coupled with significant advancements in disease modeling and drug development, alongside heightened R&D investment from both private and public entities, the market is poised for sustained growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape

Global Computational Biology Market Size by Service & CAGR (2024-2031)

• Market Overview
• Databases
• Infrastructure & Hardware
• Software Platform

Global Computational Biology Market Size by Application & CAGR (2024-2031)

• Market Overview
• Drug Discovery & Disease Modelling
  • Target Identification
  • Target Validation
  • Lead Discovery
  • Lead Optimization
• Preclinical Drug Development
  • Pharmacokinetics
  • Pharmacodynamics
• Clinical Trial
  • Phase I
  • Phase Ii
  • Phase Iii
  • Phase Iv
• Computational Genomics
• Computational Proteomics
• Others

Global Computational Biology Market Size by End-Use & CAGR (2024-2031)

• Market Overview
• Academic & Research
• Pharmaceutical Industry
• Industrial

Global Computational Biology Market Size & CAGR (2024-2031)

• North America (Service, Application, End-Use)
  • USA
  • Canada
• Europe (Service, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• DNAnexus, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schrodinger, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Compugen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aganitha AI Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedata AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Simulations Plus, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fios Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certara
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chemical Computing Group ULC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedata AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insilico Biotechnology AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations